Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleTheranostics

Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After 131I Therapy for Thyroid Cancer

Di Wu, Cristiane J. Gomes Lima, Gary Bloom, Kenneth D. Burman, Leonard Wartofsky and Douglas Van Nostrand
Journal of Nuclear Medicine March 2020, 61 (3) 397-404; DOI: https://doi.org/10.2967/jnumed.119.230730
Di Wu
1MedStar Health Research Institute, Hyattsville, Maryland
2Nuclear Medicine Research, MedStar Washington Hospital Center, Washington, District of Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristiane J. Gomes Lima
1MedStar Health Research Institute, Hyattsville, Maryland
3Division of Endocrinology, MedStar Washington Hospital Center, Washington, District of Columbia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary Bloom
4ThyCa: Thyroid Cancer Survivors’ Association, Inc., New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth D. Burman
3Division of Endocrinology, MedStar Washington Hospital Center, Washington, District of Columbia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonard Wartofsky
1MedStar Health Research Institute, Hyattsville, Maryland
3Division of Endocrinology, MedStar Washington Hospital Center, Washington, District of Columbia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas Van Nostrand
1MedStar Health Research Institute, Hyattsville, Maryland
2Nuclear Medicine Research, MedStar Washington Hospital Center, Washington, District of Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 61 no. 3 397-404
DOI 
https://doi.org/10.2967/jnumed.119.230730
PubMed 
31451488

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication May 2, 2019
  • Accepted for publication August 5, 2019
  • Published online March 2, 2020.

Article Versions

  • previous version (August 26, 2019 - 11:19).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Di Wu1,2,
  2. Cristiane J. Gomes Lima1,3,
  3. Gary Bloom4,
  4. Kenneth D. Burman3,
  5. Leonard Wartofsky1,3 and
  6. Douglas Van Nostrand1,2
  1. 1MedStar Health Research Institute, Hyattsville, Maryland
  2. 2Nuclear Medicine Research, MedStar Washington Hospital Center, Washington, District of Columbia
  3. 3Division of Endocrinology, MedStar Washington Hospital Center, Washington, District of Columbia; and
  4. 4ThyCa: Thyroid Cancer Survivors’ Association, Inc., New York, New York
  1. For correspondence or reprints contact: Douglas Van Nostrand, Nuclear Medicine Research, MedStar Washington Hospital Center, 110 Irving St., N.W., Suite GA60F, Washington, DC 20010. E-mail: douglas.van.nostrand{at}medstar.net
View Full Text

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • 1 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Impact of the COVID-19 pandemic in nuclear medicine departments: preliminary report of the first international survey
    Salvatore Annunziata, Matteo Bauckneht, Domenico Albano, Giovanni Argiroffi, Diletta Calabrò, Elisabetta Abenavoli, Flavia Linguanti, Riccardo Laudicella
    European Journal of Nuclear Medicine and Molecular Imaging 2020 47 9

Article usage

Article usage: August 2019 to April 2025

AbstractFullPdf
Aug 201923308
Sep 201920107
Oct 20199007
Nov 20194901
Dec 20196304
Jan 20205803
Feb 20205909
Mar 202013541693
Apr 2020256012
May 2020141012
Jun 202093211
Jul 20205317
Aug 20205801
Sep 20201141625
Oct 202069129
Nov 202060921
Dec 2020431818
Jan 202116276
Feb 2021274017
Mar 2021314316
Apr 2021174322
May 2021144326
Jun 2021152824
Jul 2021141714
Aug 202110109
Sep 2021132013
Oct 2021111220
Nov 2021102522
Dec 202110165
Jan 202219153
Feb 20221597
Mar 20226109
Apr 202214146
May 202261215
Jun 2022499
Jul 20225134
Aug 20223135
Sep 202271313
Oct 2022758
Nov 20225108
Dec 20229165
Jan 20238711
Feb 20235126
Mar 20233137
Apr 2023258
May 20234119
Jun 2023352
Jul 2023644
Aug 202391011
Sep 2023565
Oct 202341311
Nov 20233511
Dec 20233256
Jan 20245158
Feb 2024142
Mar 20247922
Apr 202421111
May 20242254
Jun 20245178
Jul 202482215
Aug 202491715
Sep 20245810
Oct 20247159
Nov 202481410
Dec 20247146
Jan 2025678
Feb 20256553
Mar 202553512
Apr 202542319
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 61 (3)
Journal of Nuclear Medicine
Vol. 61, Issue 3
March 1, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After 131I Therapy for Thyroid Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After 131I Therapy for Thyroid Cancer
Di Wu, Cristiane J. Gomes Lima, Gary Bloom, Kenneth D. Burman, Leonard Wartofsky, Douglas Van Nostrand
Journal of Nuclear Medicine Mar 2020, 61 (3) 397-404; DOI: 10.2967/jnumed.119.230730

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After 131I Therapy for Thyroid Cancer
Di Wu, Cristiane J. Gomes Lima, Gary Bloom, Kenneth D. Burman, Leonard Wartofsky, Douglas Van Nostrand
Journal of Nuclear Medicine Mar 2020, 61 (3) 397-404; DOI: 10.2967/jnumed.119.230730
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Theranostics

  • Can 177Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
  • Determination of the Intralesional Distribution of Theranostic 124I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
  • Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Show more Theranostics

Clinical

  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Show more Clinical

Similar Articles

Keywords

  • 131I therapy
  • differentiated thyroid cancer
  • radiation safety
  • nonprivate residence
SNMMI

© 2025 SNMMI

Powered by HighWire